The above results identified that the selected LRGs were related to the process of lipid metabolic reprogramming, oncogenesis, and inflammation in breast cancer [40–42], of which the expression of FABP7 and NDUFAB1 could affect the prognosis of patients with breast cancer. Here, FABP7 is linked to breast carcinoma.